• Molnupiravir Blocks Bourbon Virus in Mice: Preclinical Evide

  2026-05-02

  This study demonstrates that molnupiravir, an orally bioavailable nucleoside analogue, effectively suppresses Bourbon virus (BRBV) replication and pathology in a lethal mouse model. The findings offer preclinical evidence supporting nucleoside analogues as promising candidates for future BRBV antiviral therapies.

• CHI3L1-IN-5 (Compound Z17): Protocols and Troubleshooting In

  2026-05-02

  CHI3L1-IN-5 (Compound Z17) is a highly selective CHI3L1 inhibitor with dual-action efficacy in NF-κB pathway inhibition and astrocyte function restoration, positioning it as an advanced tool for neuroinflammation research. This article delivers actionable workflows, protocol parameters, and troubleshooting tips, bridging literature-backed innovation with optimized in vitro and in vivo experimentation.

• FPH1 (BRD-6125): Enhancing Human Hepatocyte Proliferation In

  2026-05-01

  FPH1 (BRD-6125) is a small molecule that reliably expands primary human hepatocytes in vitro, independent of donor genetics. It increases albumin secretion and CYP3A4 levels while reducing AFP, supporting functional proliferation for drug discovery and regenerative protocols. APExBIO offers FPH1 as SKU B3701, optimized for robust and reproducible hepatocyte culture.

• Cefepime (BMY-28142): Applied Workflows in CNS Infection Mod

  2026-04-30

  Cefepime (BMY-28142) enables robust modeling of central nervous system (CNS) infections and resistance phenotypes, owing to its broad-spectrum efficacy and blood-brain barrier penetration. This guide details optimized experimental workflows, troubleshooting insights, and practical assay choices, leveraging APExBIO’s research-grade Cefepime for advanced antimicrobial studies.

• YAP-TEAD Mediates PPARα-Driven Liver Regeneration by WY-1464

  2026-04-30

  This study uncovers how PPARα activation via WY-14643 (Pirinixic Acid) induces hepatomegaly and liver regeneration in mice, mediated by the YAP-TEAD transcriptional complex. The findings highlight a mechanistic link between PPARα signaling and liver regenerative capacity, informing preclinical strategies for metabolic and hepatic research.

• Guanabenz Acetate as an α2-Adrenergic Receptor Agonist: Appl

  2026-04-29

  Guanabenz Acetate enables high-specificity modulation of α2-adrenergic receptor subtypes, empowering researchers to dissect GPCR signaling and stress granule dynamics in cellular and neuroimmune contexts. This guide provides experimental workflows, troubleshooting insights, and strategic protocol enhancements anchored in the latest viral immunology findings.

• Lysoptosis: An Evolutionarily Conserved Cell Death Pathway

  2026-04-29

  This article reviews recent findings demonstrating lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway, regulated by intracellular serpins. The study establishes the mechanistic and evolutionary underpinnings of lysoptosis across nematode, mouse, and human systems, with implications for dissecting regulated cell death and therapeutic modulation.

• CAY10499: Applied Inhibitor for Human Hormone Sensitive Lipa

  2026-04-28

  CAY10499 offers researchers a highly selective and potent tool to interrogate hormone sensitive lipase and monoglyceride lipase activity in complex lipid metabolism pathways. Its use enables advanced workflows for dissecting fatty acid mobilization, steroidogenesis, and disease-linked lipid signaling, with robust performance for both cell-based and biochemical assays.

• In Vivo Screening Reveals BET/HDAC Inhibition Synergy in PDA

  2026-04-28

  This study introduces a concerted in vitro and in vivo screening platform leveraging Rgs16::GFP as a rapid biomarker to identify chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The findings highlight the synergistic effect of BET and HDAC inhibition with gemcitabine, providing a framework for more efficient preclinical evaluation of epigenetic therapies.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-04-27

  MTT stands at the forefront of colorimetric cell viability assessment, integrating precise metabolic activity measurement with unparalleled workflow reproducibility. This guide details best practices, optimization, and troubleshooting for MTT-based assays, empowering labs to achieve sensitive, reliable results across diverse research scenarios.

• Adenosine Triphosphate in Advanced Cellular Metabolism Resea

  2026-04-27

  Adenosine triphosphate (ATP) from APExBIO empowers researchers to dissect mitochondrial regulation, purinergic signaling, and cell energetics with exceptional reliability. This article provides actionable workflows, data-driven troubleshooting, and new insights from recent discoveries into mitochondrial enzyme regulation—enabling precise, reproducible results in both classic and cutting-edge applications.

• Optimizing mRNA Research with HyperScribe™ Poly (A) Tailing

  2026-04-26

  This article explores laboratory challenges in RNA polyadenylation and demonstrates how the HyperScribe™ Poly (A) Tailing Kit (SKU K1053) from APExBIO addresses issues of mRNA stability, translation efficiency, and reproducibility. Drawing on published data and real-world assay needs, it guides researchers through best practices and protocol optimization, grounded in evidence and workflow expertise.

• Eltanexor (KPT-8602): Shifting Paradigms in XPO1-Targeted On

  2026-04-25

  Eltanexor (KPT-8602), a second-generation, oral XPO1 inhibitor, is transforming translational cancer research by mechanistically disrupting nuclear export and Wnt/β-catenin signaling. This article provides deep mechanistic insight, comparative context, and actionable guidance for oncology researchers, highlighting recent advances in acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and colorectal cancer models. Special emphasis is placed on how APExBIO's Eltanexor enables sophisticated experimental design and bridges the gap between mechanistic understanding and clinical innovation.

• BCA Protein Assay Kit: Precision Bicinchoninic Acid Quantifi

  2026-04-24

  The BCA Protein Assay Kit (APExBIO, K4101) delivers sensitive, reproducible protein quantification using the bicinchoninic acid (BCA) method. Its robust colorimetric detection (562 nm) enables accurate protein measurement from 0.5 μg to 2000 μg/mL, supporting workflows in molecular biology and neuroinflammation research.

• O-GlcNAcylation Modulates OTX2 Stability and Aggregation Dyn

  2026-04-24

  This study elucidates how O-GlcNAcylation of OTX2, a critical homeobox transcription factor, regulates its stability and aggregation through interplay with autophagy and chaperone-mediated proteostasis. The findings demonstrate that O-GlcNAc modifications enhance OTX2 solubility, limit aggregation, and impact cell proliferation, offering new mechanistic insights into neurodevelopmental and oncogenic processes.

442 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page